ロード中...
The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan
OBJECTIVE: Hyponatremia is frequently observed in patients with decompensated liver cirrhosis and it is also related to a poor prognosis. The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic patients with ascites and increases the serum sodium (Na) level. In this study, we inv...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725852/ https://ncbi.nlm.nih.gov/pubmed/28943585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.9033-17 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|